List of Epiduo Forte drug patents

Epiduo Forte is owned by Galderma Labs.

Epiduo Forte contains Adapalene; Benzoyl Peroxide.

Epiduo Forte has a total of 9 drug patents out of which 5 drug patents have expired.

Expired drug patents of Epiduo Forte are:

  • US8785420
  • US8936800
  • US9814690
  • US8809305
  • US8445543

Epiduo Forte was authorised for market use on 15 July, 2015.

Epiduo Forte is available in gel;topical dosage forms.

Epiduo Forte can be used as treatment of acne.

The generics of Epiduo Forte are possible to be released after 12 March, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8785420 GALDERMA LABS Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(a month ago)

US8936800 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(a month ago)

US9814690 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(a month ago)

US8809305 GALDERMA LABS Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Dec, 2022

(a month ago)

US8445543 GALDERMA LABS Combinations of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(a month ago)

US9387187 GALDERMA LABS Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US9381179 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US8703820 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US8729127 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient

Market Authorisation Date: 15 July, 2015

Treatment: Treatment of acne

Dosage: GEL;TOPICAL

How can I launch a generic of EPIDUO FORTE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic